Low participation in cancer screening in India: a scoping review of breast and cervical cancer programs.
Gespeichert in:
| Titel: | Low participation in cancer screening in India: a scoping review of breast and cervical cancer programs. |
|---|---|
| Autoren: | Venghateri JB; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India., Nathani P; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India., Goyal S; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India., Sarang B; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India.; Department of Surgery, Terna Medical College & Hospital, New Mumbai, India., Rawtani H; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India., Patil P; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India.; Department of Statistics, BARC Hospital, Mumbai, India., Kv D; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India.; Laparoscopic and Robotic surgery, Max Super speciality Hospital, Max Institute of GI, Dwarka, Delhi, India., Jain N; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India., Gadgil A; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India., Roy N; WHO Collaborating Centre for Emergency, Critical and Operative Care, Mumbai, India. nobhojit.roy@ki.se.; Department of Global Public Health, Karolinska Institutet, Stockholm, 17177, Sweden. nobhojit.roy@ki.se. |
| Quelle: | BMC cancer [BMC Cancer] 2025 Nov 07; Vol. 25 (1), pp. 1724. Date of Electronic Publication: 2025 Nov 07. |
| Publikationsart: | Journal Article; Scoping Review; Systematic Review |
| Sprache: | English |
| Info zur Zeitschrift: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: London : BioMed Central, [2001- |
| MeSH-Schlagworte: | Uterine Cervical Neoplasms*/diagnosis , Uterine Cervical Neoplasms*/epidemiology , Early Detection of Cancer*/statistics & numerical data , Early Detection of Cancer*/methods , Breast Neoplasms*/diagnosis , Breast Neoplasms*/epidemiology , Mass Screening*/statistics & numerical data, Humans ; India/epidemiology ; Female |
| Abstract: | Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable to this study. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests. Background: India is witnessing a high and rising burden of breast and cervical cancers. More than one-third of cases in India are attributed to these two cancers. Early detection and access to affordable and timely treatment are known to reduce the burden of cancer-related deaths. Low and Middle-Income Countries (LMICs) face significant challenges in implementing organized early-detection programs due to inadequate resources, contributing to high mortality from these cancers. Recognizing this critical public health issue, this study evaluates the published literature and government reports on the implementation of breast and cervical cancer screening programs in India. Methods: Literature was systematically searched from six databases: PubMed, Embase, Scopus, CINAHL, Web of Science, and Google Scholar. In addition, reports on the National Health Mission website were reviewed to capture screening efforts that were not published in the peer-reviewed literature. Results: 59 peer-reviewed manuscripts were identified, from 57 screening programs. The number of screening programs from Northern and Eastern states is low. Community programs focused on task shifting and engagement of local stakeholders for increasing participation. Clinical Breast Examination (CBE) and Visual inspection of the cervix (VIA) remain the mainstay of screening efforts. The main barriers to screening uptake by women were lower education, lower socioeconomic status, lack of transportation, and suboptimal services. Information on screening programs lacked uniformity in reporting and data collection. Conclusion: These results highlight that screening efforts in India remain disjointed and programs by different agencies need to be aligned through uniform distribution, methodology, and reporting, towards goals set by global initiatives. (© 2025. The Author(s).) |
| References: | Nat Med. 2022 Apr;28(4):666-677. (PMID: 35440720) Ecancermedicalscience. 2021 Aug 19;15:1277. (PMID: 34567262) Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033) Public Health Rev. 2018 Mar 02;39:7. (PMID: 29507820) BMC Health Serv Res. 2021 Jan 4;21(1):4. (PMID: 33397388) Indian J Community Med. 2015 Jul-Sep;40(3):203-7. (PMID: 26170547) Clin Infect Dis. 2022 Oct 12;75(8):1280-1288. (PMID: 35294524) JCO Glob Oncol. 2020 Jul;6:1063-1075. (PMID: 32673076) BMC Cancer. 2020 Aug 24;20(1):795. (PMID: 32831048) Int J Cancer. 2023 Jan 15;152(2):249-258. (PMID: 35852007) Prev Med. 2020 Jun;135:106076. (PMID: 32247010) Lancet Glob Health. 2022 Apr;10(4):e461-e462. (PMID: 35303446) Indian J Cancer. 2021 Jul-Sep;58(3):417-424. (PMID: 33402583) World J Surg Oncol. 2016 Oct 28;14(1):277. (PMID: 27793162) Asian Pac J Cancer Prev. 2022 Jul 01;23(7):2361-2366. (PMID: 35901342) Ann Glob Health. 2020 Mar 16;86(1):30. (PMID: 32211300) BMC Public Health. 2019 Jan 3;19(1):14. (PMID: 30606132) Cancers (Basel). 2023 Mar 31;15(7):. (PMID: 37046773) BMC Womens Health. 2021 Mar 23;21(1):122. (PMID: 33757512) Health Policy Plan. 2023 Apr 11;38(4):509-527. (PMID: 36525529) Asian Pac J Cancer Prev. 2021 Feb 01;22(2):413-418. (PMID: 33639655) J Obstet Gynaecol India. 2021 Jun;71(3):304-312. (PMID: 34408351) South Asian J Cancer. 2019 Apr-Jun;8(2):102-107. (PMID: 31069189) Int J Cancer. 2015 Aug 15;137(4):859-67. (PMID: 25631198) Indian J Med Res. 2017 Jan;145(1):144-146. (PMID: 28574029) Womens Health (Lond). 2021 Jan-Dec;17:17455065211017066. (PMID: 34396854) Cancer Causes Control. 2016 Mar;27(3):351-8. (PMID: 26712612) Indian J Cancer. 2019 Jul-Sep;56(3):222-227. (PMID: 31389385) Asian Pac J Cancer Prev. 2019 Dec 01;20(12):3703-3710. (PMID: 31870112) Cancer Epidemiol. 2021 Oct;74:101982. (PMID: 34280846) Indian J Cancer. 2022 Jan-Mar;59(1):39-45. (PMID: 34380836) J Glob Oncol. 2018 Jul;4:1-10. (PMID: 30085882) Asian Pac J Cancer Prev. 2020 Dec 01;21(12):3509-3515. (PMID: 33369446) Lancet Oncol. 2014 May;15(6):e205-12. (PMID: 24731885) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) Cancer Control. 2021 Jan-Dec;28:10732748211010799. (PMID: 33926235) J Cancer Educ. 2020 Jun;35(3):579-588. (PMID: 30863980) Front Glob Womens Health. 2021 Jul 19;2:697607. (PMID: 34816234) Cancer. 2023 Jan 15;129(2):272-282. (PMID: 36321193) J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. (PMID: 18780864) Asian Pac J Cancer Prev. 2022 Jan 01;23(1):327-338. (PMID: 35092402) Indian J Cancer. 2018 Oct-Dec;55(4):318-326. (PMID: 30829264) BMC Womens Health. 2023 Jan 7;23(1):7. (PMID: 36611149) J Epidemiol Glob Health. 2020 Mar;10(1):28-35. (PMID: 32175707) J Glob Oncol. 2018 Sep;4:1-3. (PMID: 30241157) Eur J Cancer Prev. 2018 Nov;27(6):546-552. (PMID: 28704213) J Med Virol. 2023 Apr;95(4):e28715. (PMID: 37185837) Int J Cancer. 2005 Dec 20;117(6):981-7. (PMID: 16003735) J Obstet Gynaecol Res. 2020 Feb;46(2):320-327. (PMID: 31814247) Syst Rev. 2013 Apr 08;2:20. (PMID: 23566447) J Family Med Prim Care. 2022 Nov;11(11):7303-7307. (PMID: 36992989) Asian Pac J Cancer Prev. 2021 Mar 01;22(3):971-976. (PMID: 33773563) J Cancer Policy. 2022 Jun;32:100324. (PMID: 35560262) Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):278-285. (PMID: 28144096) J Glob Health. 2018 Dec;8(2):020421. (PMID: 30603075) J Family Med Prim Care. 2020 Mar 26;9(3):1528-1532. (PMID: 32509644) Indian J Community Med. 2022 Jul-Sep;47(3):414-419. (PMID: 36438507) Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:41-46. (PMID: 28691337) J Perinatol. 2016 Dec;36(s3):S9-S12. (PMID: 27924110) Asian Pac J Cancer Prev. 2015;16(13):5237-42. (PMID: 26225659) Cancer Causes Control. 2025 Jan;36(1):67-79. (PMID: 39375278) Cancers (Basel). 2024 Mar 13;16(6):. (PMID: 38539469) Lancet. 2017 Dec 2;390(10111):2437-2460. (PMID: 29150201) Indian J Public Health. 2014 Jan-Mar;58(1):5-10. (PMID: 24748350) BMC Womens Health. 2023 Dec 2;23(1):643. (PMID: 38042837) Asian Pac J Cancer Prev. 2021 May 01;22(5):1393-1400. (PMID: 34048166) Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275) Prev Med. 2021 Mar;144:106322. (PMID: 33678230) Niger Postgrad Med J. 2022 Jan-Mar;29(1):63-69. (PMID: 35102952) Asian Pac J Cancer Prev. 2015;16(5):1953-8. (PMID: 25773793) Eur J Public Health. 2018 Dec 1;28(6):1156-1162. (PMID: 30346504) Asian Pac J Cancer Prev. 2019 Mar 26;20(3):917-923. (PMID: 30912415) Breast. 2017 Feb;31:85-89. (PMID: 27829200) Acta Cytol. 2018;62(4):273-278. (PMID: 29898440) Cancer. 2022 May 1;128(9):1757-1766. (PMID: 35133005) Indian J Community Med. 2018 Apr-Jun;43(2):86-89. (PMID: 29899606) Asian Pac J Cancer Prev. 2015;16(3):859-62. (PMID: 25735373) J Indian Med Assoc. 1993 Apr;91(4):94-6. (PMID: 8409491) Br J Surg. 2017 Sep;104(10):1315-1326. (PMID: 28783227) Eur J Cancer Prev. 2005 Dec;14(6):513-8. (PMID: 16284495) Eur J Cancer. 2015 Sep;51(14):2058-66. (PMID: 26232859) Health Res Policy Syst. 2020 Jan 7;18(1):2. (PMID: 31910868) |
| Contributed Indexing: | Keywords: Breast neoplasms; Diagnostic screening programs; Early detection of cancer; India; Uterine cervical neoplasms |
| Entry Date(s): | Date Created: 20251107 Date Completed: 20251108 Latest Revision: 20251112 |
| Update Code: | 20251112 |
| PubMed Central ID: | PMC12593890 |
| DOI: | 10.1186/s12885-025-14859-6 |
| PMID: | 41204154 |
| Datenbank: | MEDLINE |
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable to this study. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.<br />Background: India is witnessing a high and rising burden of breast and cervical cancers. More than one-third of cases in India are attributed to these two cancers. Early detection and access to affordable and timely treatment are known to reduce the burden of cancer-related deaths. Low and Middle-Income Countries (LMICs) face significant challenges in implementing organized early-detection programs due to inadequate resources, contributing to high mortality from these cancers. Recognizing this critical public health issue, this study evaluates the published literature and government reports on the implementation of breast and cervical cancer screening programs in India.<br />Methods: Literature was systematically searched from six databases: PubMed, Embase, Scopus, CINAHL, Web of Science, and Google Scholar. In addition, reports on the National Health Mission website were reviewed to capture screening efforts that were not published in the peer-reviewed literature.<br />Results: 59 peer-reviewed manuscripts were identified, from 57 screening programs. The number of screening programs from Northern and Eastern states is low. Community programs focused on task shifting and engagement of local stakeholders for increasing participation. Clinical Breast Examination (CBE) and Visual inspection of the cervix (VIA) remain the mainstay of screening efforts. The main barriers to screening uptake by women were lower education, lower socioeconomic status, lack of transportation, and suboptimal services. Information on screening programs lacked uniformity in reporting and data collection.<br />Conclusion: These results highlight that screening efforts in India remain disjointed and programs by different agencies need to be aligned through uniform distribution, methodology, and reporting, towards goals set by global initiatives.<br /> (© 2025. The Author(s).) |
|---|---|
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-025-14859-6 |